Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NURECA.NSthis companyNureca Limited	₹302.10	97.99×	1.13×	1.39×	19.3×	-54.1%	24.0%	4.4%	1.4%	1.2%	1.5%	0.9%	0.01×	-4.6×	5.07×	8.32×	0.0%	5	5.79	3	B-
AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited	₹109.04	36.51×	0.96×	0.31×	14.58×	-99.9%	3.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	3.66×	0.86×	1.81×	0.0%	6	—	2	C
AASHKA.BOAashka Hospitals Limited	₹95.80	41.26×	1.33×	5.99×	27.04×	-78.8%	54.9%	9.9%	14.5%	3.2%	1.7%	2.8%	0.08×	0.75×	1.92×	2.8×	0.0%	8	12.13	2	B-
AMBALALSA.BOAmbalal Sarabhai Enterprises Limited	₹35.63	10.46×	1.18×	0.92×	20.11×	-8.8%	23.1%	3.9%	8.8%	11.2%	3.5%	3.9%	0.36×	4.28×	1.91×	1.27×	0.0%	3	—	2	C+
BDH.BOBDH Industries Limited	₹414.55	18.78×	2.64×	2.12×	10.9×	99.9%	18.4%	13.6%	11.3%	14.0%	11.4%	-0.1%	0.03×	-1.7×	213.65×	4×	1.3%	4	—	2	B-
OXYGENTAPH.BOOxygenta Pharmaceutical Ltd.	₹50.00	-10.19×	-4.19×	1.58×	-18.64×	-1043.4%	0.8%	-15.7%	-15.6%	41.2%	-20.6%	-25.3%	-2.57×	-6.99×	-3.7×	0.6×	0.0%	3	1.14	1	D+
Peer median	—	18.78×	1.18×	1.58×	14.58×	-78.8%	18.4%	3.9%	8.8%	11.2%	1.7%	-0.1%	0.08×	0.75×	1.91×	1.81×	0.0%	4	6.63	2	—